NCT03766568

Brief Summary

This is a pilot study to assess the first time use of the JGG endoscope® in humans and in primary care. The JGG endoscope® is attached to a Heine® otoscope and allows to inspect and to collect samples from the middle meatus of the sinus. The JGG endoscope® is sterile packaged, for one way use and disposable.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 6, 2018

Completed
11 days until next milestone

Study Start

First participant enrolled

December 17, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

January 14, 2020

Status Verified

January 1, 2020

Enrollment Period

1.5 years

First QC Date

December 3, 2018

Last Update Submit

January 13, 2020

Conditions

Keywords

Rhinosinusitisupper respiratory tract infectionantibioticendoscopyOtolaryngologyprimary care

Outcome Measures

Primary Outcomes (2)

  • Prevalence of successful JGG endoscope® application

    The number of patients with successful visualization and sample collection from the middle meatus with the JGG endoscope®

    Baseline Day 0

  • Prevalence of complications

    The number of patients with complications related to the examination with the JGG endoscope®.

    2 weeks follow-up

Secondary Outcomes (7)

  • Influence of JGG endoscope® to support the decision of antibiotic prescribing

    one weeks follow-up

  • Prevalence of bacterial Rhinosinusitis

    2 weeks follow-up

  • Prevalence of any or deferred antibiotic prescriptions

    2 weeks follow-up

  • Number of days with restrictions

    2 weeks follow-up

  • Patients's acceptability of JGG endoscope®

    one week follow-up

  • +2 more secondary outcomes

Study Arms (1)

Diagnostic with JGG endoscope

EXPERIMENTAL
Device: JGG endoscope(R)

Interventions

The JGG endoscope(R) is attached to the new generation of Heine® otoscopes with a LED light source that allows the inspection of the ostium in the middle meatus and collection of material for bacterial culture for the diagnosis of ABRS in primary care. After local anaesthesiology of the cavum nasi a sample material for cultures can be gained (earliest 10 min after local anaesthesia). The diagnostic procedure poses patients at minimal risk for complications and is of very little and short-termed discomfort.

Diagnostic with JGG endoscope

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults patients aged ≥18 years, with acute rhinosinusitis
  • Duration: worsening of symptoms after 5 days after onset of symptoms or if symptoms persist for more than 10 days, but no longer than 28 days. In addition, Criteria 1 and 2 must be fulfilled.
  • Criteria 1 for acute rhinosinusitis:
  • \[Nasal blockage/obstruction/congestion OR Nasal Discharge (anterior/ posterior nasal drip)\] AND \[Facial pain/ pressure OR Reduction or loss of smell\]
  • Criteria 2 for acute bacterial rhinosinusitis
  • Indicated by the presence of at least one of the following symptoms:
  • discoloured discharge (unilateral predominance)
  • severe local pain (unilateral predominance)
  • fever, that is \>38°C
  • elevated inflammatory markers (CRP)
  • 'double sickening' whereby the patient's condition deteriorates.

You may not qualify if:

  • Not being able to provide written informed consent in German (due to any mental or intellectual problem or other reasons)
  • Not being available for follow-up
  • Previous participation in Sinus-Endo study
  • Use of antibiotic the last 4 weeks
  • Known pathology or malformation of the sinuses or nasal cavity (like polyposis)
  • Known pregnancy
  • Allergic reactions to local anaesthetics
  • Anticoagulation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Praxis Vogt

Liestal, Basel-Landschaft, 4410, Switzerland

RECRUITING

Hausarztpraxis Muttenz AG

Muttenz, Basel-Landschaft, 4132, Switzerland

RECRUITING

mediX toujours Pratteln

Pratteln, Basel-Landschaft, 4133, Switzerland

RECRUITING

HNO Klinik, University Hospital Basel

Basel, Canton of Basel-City, 4031, Switzerland

RECRUITING

mediX toujours Basel

Basel, Canton of Basel-City, 4051, Switzerland

RECRUITING

Praxis Hammer

Basel, Canton of Basel-City, 4057, Switzerland

NOT YET RECRUITING

Related Publications (1)

  • Glinz D, Georg Hansen J, Trutmann C, Schaller B, Vogt J, Diermayr C, Marti A, Leitmeyer K, Doerig P, Zeller A, Welge-Luessen Lemcke A, Bucher HC. Single-use device endoscopy for the diagnosis of acute bacterial rhinosinusitis in primary care: A pilot and feasibility study. Clin Otolaryngol. 2021 Sep;46(5):1050-1056. doi: 10.1111/coa.13785. Epub 2021 May 24.

MeSH Terms

Conditions

RhinosinusitisRespiratory Tract Infections

Condition Hierarchy (Ancestors)

RhinitisInfectionsSinusitisParanasal Sinus DiseasesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Heiner C Bucher, Prof.

    CEB

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dominik Glinz, Dr. sc.

CONTACT

Heiner C Bucher, Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Prospective observational cohort study (single arm study)
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 3, 2018

First Posted

December 6, 2018

Study Start

December 17, 2018

Primary Completion

May 31, 2020

Study Completion

September 30, 2020

Last Updated

January 14, 2020

Record last verified: 2020-01

Locations